Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
Grey matter lesions in MS: From histology to clinical implications.
[Clinical study of optic neuritis combined with viral hepatitis].
Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia.
[Review on domestic published papers regarding the acute disseminated encephalomyelitis and its relations with rabies vaccination].
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.
Diagnosis and classification of autoimmune optic neuropathy.
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica.
The Choroid Plexus in Healthy and Diseased Brain.
A review of current and emerging therapeutic strategies in multiple sclerosis.
Use and medicalization of marihuana in cancer patients.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
[Optic Neuritis.]
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Platelets and neurovascular inflammation.
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
Treatment of Acute Relapses in Multiple Sclerosis.

Pages